Conditions: Postherpetic Neuralgia
Keywords: pain herpetic neuralgia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 567
Healthy volunteers: no

Brief summary:
The primary objective of the study is to assess the efficacy of eslicarbazepine acetate (ESL) as therapy for patients with post-herpetic neuralgia.

Detailed description:

Arms:
arm 1: ESL 400 mg twice-daily arm 2: ESL 800 mg once-daily arm 3: ESL 600 mg twice daily arm 4: ESL 1200 mg once daily arm 5: ESL 800 mg twice daily arm 6: placebo

Interventions: intervention 1: Eslicarbazepine acetate intervention 2: Placebo
Intervention descriptions: intervention 1: Scored tablets intervention 2: oral route

Protocol document: